
Amphastar Pharmaceuticals AMPH
$ 25.76
0.19%
Quarterly report 2025-Q3
added 11-06-2025
Amphastar Pharmaceuticals P/S Ratio 2011-2025 | AMPH
Annual P/S Ratio Amphastar Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.79 | 3.49 | 3.52 | 3.02 | 2.36 | 2.82 | 3.5 | 3.63 | 2.7 | 2.15 | 2.42 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.63 | 1.79 | 2.86 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AbbVie
ABBV
|
22.7 | $ 223.01 | -0.99 % | $ 395 B | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
24.5 | $ 4.68 | 1.85 % | $ 777 M | ||
|
Aclaris Therapeutics
ACRS
|
8.13 | $ 3.38 | 3.21 % | $ 261 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Ascendis Pharma A/S
ASND
|
947 | $ 212.3 | 5.5 % | $ 5 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Aptorum Group Limited
APM
|
105 | $ 1.33 | -1.48 % | $ 7.25 M | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.4 | 1.49 % | $ 8.18 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
AstraZeneca PLC
AZN
|
2.17 | $ 90.34 | -1.28 % | $ 96.9 B | ||
|
Anika Therapeutics
ANIK
|
2.24 | $ 9.53 | -1.19 % | $ 140 M | ||
|
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Biogen
BIIB
|
2 | $ 173.03 | -2.55 % | $ 25.2 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.33 | 2.3 % | $ 14.6 M | ||
|
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | ||
|
Baudax Bio
BXRX
|
0.614 | - | 0.59 % | $ 63 K | ||
|
Catalyst Biosciences
CBIO
|
0.296 | $ 15.32 | 5.73 % | $ 1.01 B | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
ChromaDex Corporation
CDXC
|
4.32 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
19.1 | $ 586.28 | 3.15 % | $ 44.4 B | ||
|
Cerus Corporation
CERS
|
1.49 | $ 2.14 | 13.23 % | $ 395 M | ||
|
Checkpoint Therapeutics
CKPT
|
3.91 K | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
3.58 | - | -16.75 % | $ 25.8 M | ||
|
Celldex Therapeutics
CLDX
|
0.187 | $ 28.33 | 0.5 % | $ 1.82 M | ||
|
Clovis Oncology
CLVS
|
1.55 | - | -7.23 % | $ 13 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 0.29 | -5.01 % | $ 631 M | ||
|
Benitec Biopharma
BNTC
|
54.5 | $ 12.91 | 0.78 % | $ 531 M | ||
|
Cytokinetics, Incorporated
CYTK
|
0.286 | $ 60.38 | 0.11 % | $ 6.76 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 95.9 | 0.17 % | $ 27.2 B | ||
|
Deciphera Pharmaceuticals
DCPH
|
7.34 | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 | $ 11.55 | 8.86 % | $ 747 M | ||
|
Dynavax Technologies Corporation
DVAX
|
6.24 | $ 10.89 | -0.09 % | $ 1.42 B | ||
|
Eloxx Pharmaceuticals
ELOX
|
48.8 | - | -5.68 % | $ 8.28 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M |